Stockreport

Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody

AEVI GENOMIC MEDICINE INC  (GNMX) 
Last aevi genomic medicine inc earnings: 11/14 08:01 am Check Earnings Report
US:NASDAQ Investor Relations: aevigenomics.com
PDF PHILADELPHIA, Aug. 7, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "Aevi") today announced that it has obtained the right to exercise an exclusive glo [Read more]